<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01493388</url>
  </required_header>
  <id_info>
    <org_study_id>INS-3914</org_study_id>
    <secondary_id>U1111-1124-9862</secondary_id>
    <nct_id>NCT01493388</nct_id>
  </id_info>
  <brief_title>To Estimate the Percentage of Children and Adolescents in Tunisia With Acceptably Controlled Diabetes Mellitus Type 1</brief_title>
  <official_title>Observational, Cross-sectional and Retrospective Study on Diabetes Mellitus Type 1 in Tunisian Children and Adolescents Under 15 Years</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novo Nordisk A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novo Nordisk A/S</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is conducted in Africa. The aim of this study is to estimate the percentage of
      children and adolescents below or equal to 15 years in Tunisia with acceptably controlled
      diabetes mellitus type 1.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of children below 6 years with HbA1c less than 8.5%</measure>
    <time_frame>one assessment during a 5 month period is made, by review of the patient's medical records and/or interview (only 1)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of children between 6-12 years with HbA1c less than 8%</measure>
    <time_frame>one assessment during a 5 month period is made, by review of the patient's medical records and/or interview (only 1)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of adolescents between 13 and 15 years with HbA1c less than 7.5%</measure>
    <time_frame>one assessment during a 5 month period is made, by review of the patient's medical records and/or interview (only 1)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fasting plasma glucose (FPG) level</measure>
    <time_frame>one assessment during a 5 month period is made, by review of the patient's medical records and/or interview (only 1)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure level in children 12 years or older</measure>
    <time_frame>one assessment during a 5 month period is made, by review of the patient's medical records and/or interview (only 1)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total cholesterol and LDL-cholesterol levels in children 12 years or older</measure>
    <time_frame>one assessment during a 5 month period is made, by review of the patient's medical records and/or interview (only 1)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of children with evaluation of thyroid function within the last 2 years</measure>
    <time_frame>one assessment during a 5 month period is made, by review of the patient's medical records and/or interview (only 1)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of children with nephropathy</measure>
    <time_frame>one assessment during a 5 month period is made, by review of the patient's medical records and/or interview (only 1)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of children with microalbuminuria</measure>
    <time_frame>one assessment during a 5 month period is made, by review of the patient's medical records and/or interview (only 1)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of children with hypoglycemia event having led to hospitalization</measure>
    <time_frame>one assessment during a 5 month period is made, by review of the patient's medical records and/or interview (only 1)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of children with self-monitoring of blood-glucose</measure>
    <time_frame>one assessment during a 5 month period is made, by review of the patient's medical records and/or interview (only 1)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of parents and children having received at least one training and topic of the received training</measure>
    <time_frame>one assessment during a 5 month period is made, by review of the patient's medical records and/or interview (only 1)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type and dose of insulin treatment</measure>
    <time_frame>one assessment during a 5 month period is made, by review of the patient's medical records and/or interview (only 1)</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">402</enrollment>
  <condition>Diabetes</condition>
  <condition>Diabetes Mellitus, Type 1</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>insulin</intervention_name>
    <description>Patients will be treated according to routine clinical practice at the discretion of the treating physician.</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be treated according to routine clinical practice at the discretion of the
        treating physician.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent obtained before any study-related activities. (Study-related
             activities are any procedure related to recording of data according to the protocol).

          -  Child or adolescent below or equal to 15 years with diabetes mellitus type 1

          -  Who has been undergoing treatment for diabetes for at least 6 months

        Exclusion Criteria:

          -  Previous participation in this study.

          -  Current participation to a clinical trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Global Clinical Registry (GCR, 1452)</last_name>
    <role>Study Director</role>
    <affiliation>Novo Nordisk A/S</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Tunisia</city>
        <zip>1053</zip>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Tunisia</country>
  </location_countries>
  <link>
    <url>http://novonordisk-trials.com</url>
    <description>Clinical Trials at Novo Nordisk</description>
  </link>
  <results_reference>
    <citation>Hachicha M, Kamoun T, Briki S, Ouamara N. Étude observationnelle sur le diabète de type 1 chez les enfants et les adolescents de moins de 15 ans. La Revue Maghrebine d'Endocrinologie - Diabète et Reproduction; 19 (4): 144-149</citation>
  </results_reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 14, 2011</study_first_submitted>
  <study_first_submitted_qc>December 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2011</study_first_posted>
  <last_update_submitted>January 18, 2017</last_update_submitted>
  <last_update_submitted_qc>January 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

